StockData
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

TFA Therapeutics, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$9.18+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

TFA Therapeutics, Inc. revenue by segment

No segment breakdown reported

TFA Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.